AmerisourceBergen Market Cap 2006-2018 | ABC

AmerisourceBergen market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. AmerisourceBergen market cap as of April 22, 2019 is $15.29B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.293B $167.940B
AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.317B 20.37
Align Technology (ALGN) United States $22.518B 57.33
McKesson (MCK) United States $21.887B 8.52
Laboratory Of America Holdings (LH) United States $14.330B 13.18
Cooper (COO) United States $13.885B 24.22
Cardinal Health (CAH) United States $13.709B 9.24
DENTSPLY SIRONA (XRAY) United States $11.127B 24.74
Henry Schein (HSIC) United States $9.192B 14.86
West Pharmaceutical Services (WST) United States $8.223B 39.69
Merit Medical Systems (MMSI) United States $3.170B 34.12
CONMED (CNMD) United States $2.242B 36.43
Patterson (PDCO) United States $2.031B 16.05
Atrion (ATRI) United States $1.612B 47.31
STAAR Surgical (STAA) United States $1.380B 115.59
Antares Pharma (ATRS) United States $0.437B 0.00
Invacare (IVC) United States $0.222B 0.00
Lifevantage (LFVN) United States $0.158B 21.27
Pro-Dex (PDEX) United States $0.063B 28.64
Endologix (ELGX) United States $0.060B 0.00
Biolase (BIOL) United States $0.049B 0.00